Skip to results
Modify your search
NARROW
1-2 of 2
Authors: J. Randolph Hecht
Sort by
Journal Article
A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma Free
Al B. Benson and others
The Oncologist, Volume 22, Issue 3, March 2017, Pages 241–e15, https://doi.org/10.1634/theoncologist.2017-0024
Published: 28 February 2017
Journal Article
A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma Free
J. Randolph Hecht and others
The Oncologist, Volume 22, Issue 3, March 2017, Pages 243–e23, https://doi.org/10.1634/theoncologist.2016-0479
Published: 28 February 2017
Advertisement
Advertisement